# Plexiform Bioscience Inc. — Form D/A

Plexiform Bioscience Inc. of DOVER, DE, a company, filed a Form D amendment with the SEC on 2025-07-18. The offering totals $2.2M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-07-18
- Form: D/A
- Accession: 0002048968-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $1.3M
- Remaining: $860K
- Minimum investment: $50K
- Investors: 14
- Date of first sale: 2024-12-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-532304

## Issuer

- Name: Plexiform Bioscience Inc.
- CIK: 0002048968
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 8 THE GREEN NO 19634, DOVER, DE, 19901
- Phone: 7085137860

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Saad Ahmad | Executive Officer | Glendale Heights, IL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-12-17](https://search.stillhousedata.com/formd/0002048968-24-000001) | D | $2.2M | $250K |

## More

- [CIK 2048968 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2048968&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002048968-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.